AmberStone Group has acquired a stake in Vītola Klīnika and has developed New Hanza Med in Riga
AmberStone Group AS has acquired a 49% stake in Vītola Klīnika and invested in its expansion and relocation to new premises, leading to the creation of New Hanza Med — a modern, multidisciplinary medical and surgical center in the New Hanza district of Riga, Latvia.
Located at Mihaila Tāla iela 1, the new facility brings together specialists from diverse healthcare fields under one roof, providing a full spectrum of services from preventive care to complex surgical procedures. With this project, the group continues to strengthen its position in the healthcare sector, aiming to bring world-class medical standards to Latvia.
AmberStone Group is a Latvia-based investment holding company founded in 2013, specializing in private equity-style investments across sectors including healthcare, hospitality, agriculture, construction, wood processing and renewable energy. The group has extensive experience and a strong track record in developing medical facilities, notably ORTO Clinic.
Vītola Klīnika offers a comprehensive range of gynecological, diagnostic and surgical services delivered by experienced specialists. Patients benefit from advanced technology, effective treatment methods and a personalized approach, ensuring a seamless continuum of care from initial consultation and diagnostics through surgery and post-operative recovery.
Oaklins’ team in Latvia acted as the exclusive buy-side advisor to AmberStone Group, supporting the investment thesis, identifying potential acquisition targets, facilitating introductions and negotiating deal terms.
Talk to the deal team
Related deals
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn more